Unidrug-target: A computational tool to identify unique drug targets in pathogenic bacteria

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Chanumolu, Sree Krishna ^a   Rout, Chittaranjan ^a   Chauhan, Rajinder S ^a  

^a JAYPEE UNIVERSITY OF INFORMATION TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; AMINO ACID SEQUENCE; ANALYTIC METHOD; ARTICLE; BACTERIUM DETECTION; CALCULATION; COMPUTER PREDICTION; COMPUTER PROGRAM; DRUG IDENTIFICATION; DRUG TARGETING; INFORMATION PROCESSING; INFORMATION RETRIEVAL; MYCOBACTERIUM; PROTEIN STRUCTURE; PROTEIN TARGETING; WEB BROWSER; BACTERIUM; BINDING SITE; BIOLOGY; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; HUMAN; INTERNET; METABOLISM; METHODOLOGY; MYCOBACTERIUM TUBERCULOSIS; PROTEIN TERTIARY STRUCTURE;

BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MYCOBACTERIUM TUBERCULOSIS;

AMINO ACID; BACTERIAL PROTEIN;

AMINO ACIDS; BACTERIA; BACTERIAL PROTEINS; BINDING SITES; COMPUTATIONAL BIOLOGY; DRUG DELIVERY SYSTEMS; HUMANS; INTERNET; METABOLIC NETWORKS AND PATHWAYS; MODELS, MOLECULAR; MYCOBACTERIUM TUBERCULOSIS; PROTEIN STRUCTURE, TERTIARY;

EID: 84858170399     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032833     Document Type: Article

References (38)

1. Ohlstein EH, Ruffolo RR Jr, Elliott JD, (2000) Drug discovery in the next millennium. Annu Rev Pharmacol Toxicol 40: 177-191.
2. Drews J, (1997) Strategic choices facing the pharmaceutical industry: a case for innovation. Drug Discov Today 2: 72-78.
3. Storteboom H, Arabi M, Davis JG, Crimi B, Pruden A, (2010) Tracking antibiotic resistance genes in the South Platte river basin using molecular signatures of urban, agricultural, and pristine sources. Environ Sci Technol 44: 7397-7404.
4. Sekirov I, Tam NM, Jogova M, Robertson ML, Li Y, Lupp C, Finlay BB, (2008) Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect Immun 76: 4726-4736.
5. Brain RA, Hanson ML, Solomon KR, Brooks BW, (2008) Aquatic plants exposed to pharmaceuticals: effects and risks. Rev Environ Contam Toxicol 192: 67-115.
6. Devasia RA, Blackman A, Gebretsadik T, Griffin M, Shintani A, et al. (2009) Fluoroquinolone resistance in Mycobacterium tuberculosis: the effect of duration and timing of fluoroquinolone exposure. Am J Respir Crit Care Med 180: 365-370.
7. Weiss K, (2009) Clostridium difficile and fluoroquinolones: is there a link?. Int J Antimicrob Agents 33: S29-S32.
8. Walke DW, Han C, Shaw J, Wann E, Zambrowicz B, Sands A, (2001) In vivo drug target discovery: identifying the best targets from the genome. Curr Opin Biotechnol 12: 626-631.
9. Ilag LL, Ng JH, Beste G, Henning SW, (2002) Emerging high-throughput drug target validation technologies. Drug Discov Today 7: S136-S142.
10. Chan JN, Nislow C, Emili A, (2010) Recent advances and method development for drug target identification. Trends Pharmacol Sci 31: 82-88.
11. Kramer R, Cohen D, (2004) Functional genomics to new drug targets. Nat Rev Drug Discov 3: 965-972.
12. Ryan TE, Patterson SD, (2002) Proteomics: drug target discovery on an industrial scale. Trends Biotechnol 20: S45-S51.
13. Jackson PD, Harrington JJ, (2005) High-throughput target discovery using cell-based genetics. Drug Discov Today 10: 53-60.
14. Austen M, Dohrmann C, (2005) Phenotype-first screening for the identification of novel drug targets. Drug Discov Today 10: 275-282.
15. Hopkins AL, Groom CR, (2002) The druggable genome. Nat Rev Drug Discov 1: 727-730.
16. Hasan S, Daugelat S, Rao PSS, Schreiber M, (2006) Prioritizing genomic drug targets in pathogens: Application to Mycobacterium tuberculosis. PLoS Comput Biol 2: e61.
17. Hajduk PJ, Hut JR, Fesik SW, (2005) Druggability indices for protein targets derived from NMR-based screening data. J Med Chem 48: 2518-2525.
18. Gao Z, Li H, Zhang H, Liu X, Kang L, Luo X, et al. (2008) PDTD: a web-accessible protein database for drug target identification. BMC Bioinformatics 9: 104.
19. Li H, Gao Z, Kang L, Zhang H, Yang K, et al. (2006) TarFisDock: a web server for identifying drug targets with docking approach. Nucleic Acids Res 34: W219-W224.
20. Li Q, Lai L, (2007) Prediction of potential drug targets based on simple sequence properties. BMC Bioinformatics 8: 353.
21. Han LY, Zheng CJ, Xie B, Jia J, Ma XH, et al. (2007) Support vector machines approach for predicting druggable proteins: recent progress in its exploration and investigation of its usefulness. Drug Discov Today 12: 304-313.
22. Gerdes S, Edwards R, Kubal M, Fonstein M, Stevens R, et al. (2006) Essential genes on metabolic maps. Curr Opin Biotechnol 17: 448-456.
23. Yeh I, Hanekamp T, Tsoka S, Karp PD, Altman RB, (2004) Computational analysis of Plasmodium falciparum metabolism: organizing genomic information to facilitate drug discovery. Genome Res 14: 917-924.
24. Kim TY, Kim HU, Lee SY, (2009) Metabolite-centric approaches for the discovery of antibacterials using genome-scale metabolic networks. Metab Eng 12: 105-111.
25. Zhang R, Lin Y, (2009) DEG 5.0, a database of essential genes in both prokaryotes and eukaryotes. Nucleic Acids Res 37: D455-D458.
26. Rahman SA, Advani P, Schunk R, Schrader R, Schomburg D, (2005) Metabolic pathway analysis web service (Pathway Hunter Tool at CUBIC). Bioinformatics 21: 1189-1193.
27. Rahman SA, Schomburg D, (2006) Observing local and global properties of metabolic pathways: 'load points' and 'choke points' in the metabolic networks. Bioinformatics 22: 1767-1774.
28. Schmidtke P, Le Guilloux V, Maupetit J, Tuffry P, (2010) fpocket: online tools for protein ensemble pocket detection and tracking. Nucleic Acids Res 38: W582-W589.
29. Vetting MW, Errey JC, Blanchard JS, (2008) Rv0802c from Mycobacterium tuberculosis: the first structure of a succinyltransferase with the GNAT fold. Acta Crystallogr Sect F Struct Biol Cryst Commun 64: 975-985.
30. Bozdogan B, Esel D, Whitener C, Browne FA, Appelbaum PC, (2003) Antibacterial susceptibility of a vancomycin-resistant Staphylococcus aureus strain isolated at the Hershey Medical Center. J Antimicrob Chemother 52: 864-868.
31. Boyle-Vavra S, Daum RS, (2007) Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin. Lab Invest 87: 3-9.
32. Ghoshal U, Garg A, Tiwari DP, Ayyagari A, (2006) Emerging vancomycin resistance in enterococci in India. Indian J Pathol Microbiol 49: 620-622.
33. Albrich WC, Monnet DL, Harbarth S, (2004) Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg Infect Dis 10: 514-517.
34. Shi R, Itagaki N, Sugawara I, (2007) Overview of anti-tuberculosis (TB) drugs and their resistance mechanisms. Mini Rev Med Chem 7: 1177-1185.
35. Zhu F, Han B, Kumar P, Liu X, Ma X, et al. (2009) Update of TTD: Therapeutic Target Database. Nucleic Acids Res 38: D787-D791.
36. Sugaya N, Ikeda K, (2009) Assessing the druggability of protein-protein interactions by a supervised machine-learning method. BMC Bioinformatics 10: 263.
37. Hambly K, Danzer J, Muskal S, Debe DA, (2006) Interrogating the druggable genome with structural informatics. Mol Divers 3: 273-281.
38. Janowski R, Panjikar S, Eddine AN, Kaufmann SH, Weiss MS, (2009) Structural analysis reveals DNA binding properties of Rv2827c, a hypothetical protein from Mycobacterium tuberculosis. J Struct Funct Genomics 10: 137-150.